DK1753457T3 - Cationic bakterieklorofylderivater and uses - Google Patents

Cationic bakterieklorofylderivater and uses Download PDF

Info

Publication number
DK1753457T3
DK1753457T3 DK05749886.7T DK05749886T DK1753457T3 DK 1753457 T3 DK1753457 T3 DK 1753457T3 DK 05749886 T DK05749886 T DK 05749886T DK 1753457 T3 DK1753457 T3 DK 1753457T3
Authority
DK
Denmark
Prior art keywords
amide
compound
oxo
palladium
methoxycarbonylmethyl
Prior art date
Application number
DK05749886.7T
Other languages
Danish (da)
English (en)
Inventor
Avigdor Scherz
Alexander Brandis
Yoram Salomon
Doron Eren
Avraham Cohen
Original Assignee
Yeda Res & Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yeda Res & Dev filed Critical Yeda Res & Dev
Application granted granted Critical
Publication of DK1753457T3 publication Critical patent/DK1753457T3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D229/00—Heterocyclic compounds containing rings of less than five members having two nitrogen atoms as the only ring hetero atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/22—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains four or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/409—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil having four such rings, e.g. porphine derivatives, bilirubin, biliverdine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/555—Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
    • A61K41/0071—PDT with porphyrins having exactly 20 ring atoms, i.e. based on the non-expanded tetrapyrrolic ring system, e.g. bacteriochlorin, chlorin-e6, or phthalocyanines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Dermatology (AREA)
  • Oncology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Urology & Nephrology (AREA)
  • Virology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK05749886.7T 2004-06-07 2005-06-07 Cationic bakterieklorofylderivater and uses DK1753457T3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US57719604P 2004-06-07 2004-06-07
PCT/IL2005/000602 WO2005120573A2 (en) 2004-06-07 2005-06-07 Cationic bacteriochlorophyll derivatives and uses thereof

Publications (1)

Publication Number Publication Date
DK1753457T3 true DK1753457T3 (en) 2016-12-05

Family

ID=35044538

Family Applications (2)

Application Number Title Priority Date Filing Date
DK05749886.7T DK1753457T3 (en) 2004-06-07 2005-06-07 Cationic bakterieklorofylderivater and uses
DK10012927.9T DK2322173T3 (en) 2004-06-07 2005-06-07 Cationic bakterioklorofylderivater and uses thereof

Family Applications After (1)

Application Number Title Priority Date Filing Date
DK10012927.9T DK2322173T3 (en) 2004-06-07 2005-06-07 Cationic bakterioklorofylderivater and uses thereof

Country Status (19)

Country Link
US (1) US8207154B2 (https=)
EP (2) EP1753457B8 (https=)
JP (1) JP5372371B2 (https=)
KR (1) KR101191700B1 (https=)
CN (1) CN1980661B (https=)
AU (1) AU2005251556B2 (https=)
BR (1) BRPI0511909A (https=)
CA (1) CA2569675C (https=)
CY (2) CY1118203T1 (https=)
DK (2) DK1753457T3 (https=)
ES (2) ES2602460T3 (https=)
HU (2) HUE031075T2 (https=)
MX (1) MXPA06014326A (https=)
NO (2) NO339304B1 (https=)
NZ (1) NZ551845A (https=)
PT (2) PT2322173T (https=)
RU (1) RU2397172C2 (https=)
WO (1) WO2005120573A2 (https=)
ZA (1) ZA200700169B (https=)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2008665A1 (fr) * 2007-06-25 2008-12-31 Steba Biotech N.V. Formulation injectable pour thérapie photodynamique
AU2009219682B2 (en) 2008-02-27 2015-06-18 Yeda Research & Development Co. Ltd RGD-(bacterio)chlorophyll conjugates for photodynamic therapy and imaging of necrotic tumors
RU2632439C2 (ru) * 2011-08-23 2017-10-04 Йеда Рисерч Энд Дивелопмент Ко., Лтд. Фотосенсибилизаторы на основе (бактерио)хлорофилла для лечения глазных заболеваний и расстройств
ES2849427T3 (es) 2013-03-11 2021-08-18 Tookad Ip Sarl Método de producción de bacterioclorofila A
RU2548675C9 (ru) * 2013-05-29 2015-11-10 Федеральное государственное бюджетное образовательное учреждение высшего профессионального образования "Московский государственный университет тонких химических технологий имени М.В. Ломоносова" (МИТХТ им. М.В. Ломоносова) Аминоамиды в ряду бактериохлорофилла a, обладающие фотодинамической активностью, и способ их получения
JP6218073B2 (ja) * 2013-11-26 2017-10-25 国立大学法人群馬大学 細胞・組織内酸素濃度測定のための高感度近赤外りん光イリジウム錯体
RU2549953C2 (ru) * 2013-12-25 2015-05-10 Федеральное государственное унитарное предприятие Государственный научный центр "Научно-исследовательский институт органических полупродуктов и красителей" (ФГУП "ГНЦ "НИОПИК") Фотосенсибилизатор для фотодинамической терапии
RU2610566C1 (ru) * 2015-09-17 2017-02-13 Сергей Сергеевич Брусов Способ фотодинамической терапии локальных очагов инфекции
CN105424857A (zh) * 2015-12-01 2016-03-23 浙江汇能生物股份有限公司 一种二甲基半胱胺盐酸盐的高效液相色谱分析方法
WO2018102252A1 (en) * 2016-11-30 2018-06-07 North Carolina State University Methods for making bacteriochlorin macrocycles comprising an annulated isocyclic ring and related compounds
BR112021014592A2 (pt) * 2019-01-25 2021-10-05 Suncor Energy Inc. Compostos fotosensibilizadores, métodos de fabricação e aplicação em plantas
US20250269031A1 (en) * 2020-11-24 2025-08-28 The Regents Of The University Of California Mitochondria targeting quinolinium-drug conjugates and their self-assembling nanoformulations for cancer therapy
CN115093422B (zh) * 2022-06-15 2023-06-20 西北工业大学 一种基于代谢标记策略的新型光敏剂及其制备方法和应用

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3050296A (en) * 1960-12-19 1962-08-21 Trimborn Hans Transport roller for industrial furnaces
US3203888A (en) * 1961-04-24 1965-08-31 Exxon Research Engineering Co Treating athabaska sands utilizing a flotation gas
DE2018970A1 (de) 1970-04-21 1971-11-11 Badische Anilin- & Soda Fabrik AG, 6700 Ludwigshafen Verfahren zur Herstellung von beta-Aminoäthylsulfoniumverbindungen
US5330741A (en) * 1992-02-24 1994-07-19 The Regents Of The University Of California Long-wavelength water soluble chlorin photosensitizers useful for photodynamic therapy and diagnosis of tumors
US5744598A (en) 1992-06-19 1998-04-28 University Of Toledo Imines of porphyrins, of porphyrin derivatives, and of related compounds, and pharmaceutical compositions containing such imines
IL102645A (en) 1992-07-26 1998-02-22 Yeda Res & Dev Chlorophyll and bacteriochlorophyll derivatives, their preparation and pharmaceutical compositions comprising them
US6147195A (en) 1993-07-26 2000-11-14 Yeda Research And Development Co., Ltd. Chlorophyll and bacteriochlorophyll derivatives, their preparation and pharmaceutical compositions comprising them
IL116126A0 (en) 1995-11-24 1996-01-31 Yeda Res & Dev Process for the preparation of bacteriochlorophyllis some novel compounds of this type and pharmaceutical compositions comprising them
US5770730A (en) * 1996-03-08 1998-06-23 Health Research, Inc. Synthesis of carbodimide analogs of chlorins and bacteriochlorins and their use for diagnosis and treatment of cancer
ATE347554T1 (de) * 1998-12-09 2006-12-15 Yeda Res & Dev Palladiumsubstituierte bakteriochlorophyllderivate und deren verwendung
IL133253A0 (en) * 1999-12-01 2001-04-30 Yeda Res & Dev Chlorophyll and bacteriochlorophyll esters, their preparation and pharmaceutical compositions comprising them
US6573258B2 (en) * 2000-09-27 2003-06-03 Frontier Scientific, Inc. Photodynamic porphyrin antimicrobial agents
WO2002098882A1 (en) * 2001-06-01 2002-12-12 Ceramoptec Industries, Inc. Water-soluble porphyrin derivatives for photodynamic therapy, their use and manufacture
US20030203888A1 (en) * 2001-06-06 2003-10-30 Boyle Ross William Chromophores
EP1450790A4 (en) 2001-10-03 2005-10-26 Miravant Pharm Inc PHOTOSENSIBILIZING CARBAMATE DERIVATIVES
EP1450774A4 (en) 2001-10-03 2005-10-26 Miravant Pharm Inc CHLORINE PHOTOSENSIBILIZERS FOR USE IN PHOTODYNAMIC THERAPY
DE10154436A1 (de) 2001-11-07 2003-05-15 Rodotech Gmbh pyro-Bakteriopheophorbidderivate
GB0130778D0 (en) * 2001-12-21 2002-02-06 Catalyst Biomedica Ltd Novel compounds
RU2343829C2 (ru) 2002-05-08 2009-01-20 Йеда Рисерч Энд Дивелопмент Ко. Лтд Сенсибилизированный оперативный bold-mri способ получения изображения
EP1517684B1 (en) * 2002-06-27 2009-07-22 Health Research, Inc. Fluorinated chlorin and bacteriochlorin photosensitizers for photodynamic therapy
RU2223274C1 (ru) * 2002-09-04 2004-02-10 ООО "Фотогем" ГИДРАЗИДЫ В РЯДУ БАКТЕРИОХЛОРОФИЛЛА a, ОБЛАДАЮЩИЕ ФОТОДИНАМИЧЕСКОЙ АКТИВНОСТЬЮ, И СПОСОБ ИХ ПОЛУЧЕНИЯ
IL152900A0 (en) 2002-11-17 2003-06-24 Yeda Res & Dev Water-soluble bacteriochlorophyll derivatives and their pharmaceutical uses

Also Published As

Publication number Publication date
RU2397172C2 (ru) 2010-08-20
AU2005251556A1 (en) 2005-12-22
CA2569675A1 (en) 2005-12-22
NO20161485A1 (no) 2007-03-06
CN1980661A (zh) 2007-06-13
NO339304B1 (no) 2016-11-21
WO2005120573A3 (en) 2006-01-26
CN1980661B (zh) 2011-09-28
JP2008501780A (ja) 2008-01-24
ES2602204T3 (es) 2017-02-20
CA2569675C (en) 2015-03-17
ZA200700169B (en) 2008-05-28
EP1753457B1 (en) 2016-08-10
DK2322173T3 (en) 2016-12-05
NO20070083L (no) 2007-03-06
CY1118203T1 (el) 2017-06-28
BRPI0511909A (pt) 2008-01-15
EP2322173A1 (en) 2011-05-18
CY1118194T1 (el) 2017-06-28
EP1753457B8 (en) 2016-09-21
US8207154B2 (en) 2012-06-26
RU2006146677A (ru) 2008-07-20
ES2602460T3 (es) 2017-02-21
PT1753457T (pt) 2016-11-10
HUE031075T2 (en) 2017-06-28
NZ551845A (en) 2010-08-27
EP2322173B1 (en) 2016-08-10
HUE030586T2 (en) 2017-06-28
PT2322173T (pt) 2016-11-14
AU2005251556B2 (en) 2011-04-14
KR20070026563A (ko) 2007-03-08
WO2005120573A2 (en) 2005-12-22
JP5372371B2 (ja) 2013-12-18
US20080076748A1 (en) 2008-03-27
KR101191700B1 (ko) 2012-10-16
EP1753457A2 (en) 2007-02-21
MXPA06014326A (es) 2007-02-19

Similar Documents

Publication Publication Date Title
US10780045B2 (en) Nanoparticles for photodynamic therapy, X-ray induced photodynamic therapy, radiotherapy, chemotherapy, immunotherapy, and any combination thereof
US11826426B2 (en) Nanoscale metal-organic layers and metal-organic nanoplates for x-ray induced photodynamic therapy, radiotherapy, radiodynamic therapy, chemotherapy, immunotherapy, and any combination thereof
Huang et al. A tumor-targeted Ganetespib-zinc phthalocyanine conjugate for synergistic chemo-photodynamic therapy
DK1753457T3 (en) Cationic bakterieklorofylderivater and uses
Wang et al. Folic Acid–Conjugated Pyropheophorbide a as the Photosensitizer Tested for In Vivo Targeted Photodynamic Therapy
Kirejev et al. Photophysics and ex vivo biodistribution of β-cyclodextrin-meso-tetra (m-hydroxyphenyl) porphyrin conjugate for biomedical applications
Grin et al. Novel bacteriochlorophyll-based photosensitizers and their photodynamic activity
KR100918811B1 (ko) 클로린 ｅ６-엽산 결합 화합물 및 키토산을 함유하는 암 치료용 약학적 조성물
KR100911250B1 (ko) 신규한 클로린 ｅ６-엽산 결합 화합물의 제조방법
HK1103967B (en) Cationic bacteriochlorophyll derivatives and uses thereof
KR100918810B1 (ko) 클로린 ｅ６-엽산 결합 화합물을 함유하는 암 치료용 약학적 조성물
KR100911249B1 (ko) 신규한 클로린 ｅ６-엽산 결합 화합물
Boateng Design, synthesis and biological evaluation of folate-targeted photodynamic therapy agents